Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited released its monthly return as of 28 February 2026. The announcement states the total authorized share capital remains at 1.63 billion shares, with H shares in Hong Kong unchanged at 0.22 billion shares and A shares on the Shanghai Stock Exchange unchanged at 1.41 billion shares. Each share has a par value of RMB 1.

No movements in treasury shares or convertible instruments were reported during the period. The listed H shares continue to meet the public float requirement, indicating compliance with relevant listing rules.